Organization
Allegheny Health Network Cancer Institute
10 abstracts
Abstract
Detection of peritoneal metastases during cytoreductive surgery using pegsitacianine, a pH sensitive imaging agent: Final results from a phase 2 study.Org: Wake Forest University Department of General Internal Medicine, Wake Forest Baptist Health, University of Pennsylvania, OncoNano Medicine, Allegheny Health Network Cancer Institute,
Abstract
Comparison of tumor immune microenvironments (TIMEs) between primary and metastatic sites (Mets) in triple-negative breast cancer (TNBC).Org: Cedars-Sinai Medical Center, City of Hope National Medical Center, Washington University in St. Louis, Allegheny Health Network Cancer Institute, Tempus AI,
Abstract
A phase III randomized trial of radiotherapy optimization for low-risk HER2-positive breast cancer (HERO): NRG-BR008.Org: Memorial Sloan Kettering Cancer Center, The University of Texas MD Anderson Cancer Center, NRG Oncology Statistical and Data Management Center, Department of Biostatistics at University of Pittsburgh School of Public Health, Women and Infants Hospital of Rhode Island,
Abstract
NRG-BR007: A phase III trial evaluating de-escalation of breast radiation (DEBRA) following breast-conserving surgery of stage 1, HR+, HER2-, RS ≤18 breast cancer.Org: University of Kansas Medical Center Comprehensive Cancer Center (KUMC CCC), Department of Biostatistics, University of Pittsburgh School of Public Health, St. Luke’s University Health Network Cancer Center, Orlando Health Cancer Institute, The Ohio State University Comprehensive Cancer Center,
Abstract
Cancer statistics: The United States vs. worldwide.Org: Mercy Catholic Medical Center, Lansdowne, PA, Virginia Commonwealth University School of Medicine, Maimonides Medical Center, Brooklyn, NY, Allegheny Health Network Cancer Institute,
Abstract
Can teclistamab be safely administered in the community? A single-center experience.Org: Allegheny Health Network Cancer Institute,
Abstract
Concordance of circulating and solid tumor DNA through comprehensive genomic profiling in a large integrated cancer network.Org: Allegheny Health Network Cancer Institute, Illumina, Inc.,
Abstract
A multi-cohort phase I/IIa clinical trial to evaluate the safety, tolerability, and pharmacokinetics of TST001 administered as a monotherapy, with nivolumab or standard of care in patients with locally advanced or metastatic solid tumors: TransStar101.Org: Memorial Sloan Kettering Cancer Center, University of Kansas Medical Center Department of Internal Medicine, NSABP/NRG Oncology and Wake Forest University Baptist Medical Center, Gettysburg Cancer Center, University of Arizona Cancer Center,
Abstract
Racial and socioeconomic disparities in time to chemotherapy and survival in patients with pancreatic cancer.Org: Allegheny General Hospital, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, Allegheny Health Network Cancer Institute, Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, SongDang Institute for Cancer Research, Yonsei University College of Medicine, Seoul, South Korea,
Abstract
Does low-grade follicular lymphoma with high proliferation index require a different treatment strategy? A single center experience.Org: Allegheny General Hospital, Pittsburgh, PA, Allegheny Health Network Cancer Institute, Philadelphia College of Osteopathic Medicine, Philadelphia, PA,